Trending News

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

BREAKING: District Court Restores Status Quo Ante At NLRB

Update: Federal Judge Reinstates National Labor Relations Board (NLRB) Member (US)

Virginia Poised to Become Second State to Enact Comprehensive AI Legislation

Michigan Federal Court Holds CTA Reporting Rule Unconstitutional, Enjoins Enforcement Against Named Plaintiffs

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
Posted On Wednesday, March 26, 2025
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
Posted On Wednesday, March 26, 2025
Tevogen Bio CEO Named to NJBIZ 2025 Health Care Power List as Company Advances Commercialization; Reaffirms Timeframe on Previously Announced Forecast
Posted On Wednesday, March 26, 2025
Atea Pharmaceuticals Highlights Actions Underway to Enhance Shareholder Value
Posted On Wednesday, March 26, 2025
Bluejay Therapeutics Announces First Patient Dosed in AZURE-1 Global Pivotal Clinical Trial Evaluating Brelovitug (BJT-778) as a Monotherapy Treatment for Chronic Hepatitis D
Posted On Wednesday, March 26, 2025
Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry
Posted On Wednesday, March 26, 2025
Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces its Novel Inhibitors Show Promising In Silico Activity Against Measles and Related Viruses
Posted On Wednesday, March 26, 2025
MBX Biosciences to Participate in the 24th Annual Needham Virtual Healthcare Conference
Posted On Wednesday, March 26, 2025
aTyr Pharma Announces the Appointment of Dalia R. Rayes as Head of Commercial, Global Efzofitimod Franchise
Posted On Wednesday, March 26, 2025
E-Star BioTech Announces Presentation During 2025 Annual Meeting of the American College of Cardiology
Posted On Wednesday, March 26, 2025
Acumen Pharmaceuticals Completes Enrollment of ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer’s Disease
Posted On Wednesday, March 26, 2025
Aligos Therapeutics Presents Positive Data at APASL 2025
Posted On Wednesday, March 26, 2025
Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 28, 2025
Posted On Wednesday, March 26, 2025
Calidi Biotherapeutics and City of Hope Provide Update on a Phase 1 Clinical Trial with CLD-101 Virotherapy in Patients with Recurrent High-Grade Glioma
Posted On Wednesday, March 26, 2025
Starton Therapeutics to Present Poster at the American Association for Cancer Research (AACR) Annual Meeting 2025
Posted On Wednesday, March 26, 2025
Dewpoint Therapeutics announces upcoming presentations at AACR 2025
Posted On Wednesday, March 26, 2025
Intellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Nexiguran Ziclumeran (nex-z) for the Treatment of Transthyretin (ATTR) Amyloidosis with Cardiomyopathy
Posted On Wednesday, March 26, 2025
Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing
Posted On Wednesday, March 26, 2025
Kura Oncology Announces Preclinical Data for KO-2806 Selected for Oral Presentation at the 2025 AACR Annual Meeting
Posted On Wednesday, March 26, 2025
Rezolute Announces Appointment of Rare Disease Commercial Leader Erik Harris to its Board of Directors
Posted On Wednesday, March 26, 2025
Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531
Posted On Wednesday, March 26, 2025
Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights
Posted On Wednesday, March 26, 2025
Medicenna to Provide Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming American Association for Cancer Research Annual Meeting
Posted On Wednesday, March 26, 2025
Ascentage Pharma to Present Five Preclinical Studies from Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2025
Posted On Tuesday, March 25, 2025
Biomea Fusion Announces Leadership Transition
Posted On Tuesday, March 25, 2025

Print